Wednesday, September 1, 2010

Respiratory Care Article Details Problems with CPAP Adherence.

The Respiratory Journal looks at problems related to CPAP adherence. The September 2010 article states "Adverse effects such as nasal congestion, dry mouth, or skin irritation occur in approximately 50% of CPAP users" These side effects are only a few of the problems patients experience that lead to CPAP non-compliance. There are many advances in CPAP treatment that have little effect for most patients on CPAP success. The article states "The use of sophisticated therapy modalities such as auto-titration or bi-level PAP units has been shown to improve adherence in certain subsets of OSA patients" but other research shows little change in CPAP compliance rates. The problems associated with CPAP are the reasons so mmany patients exclaim "I HATE CPAP!".

What kind of patient does not do well with CPAP? The article further states " though a search for consistent predictive factors related to CPAP adherence has proven elusive. Other influences, such as sex, age, socioeconomic status, and personality traits are less robust predictors." In essence all types of patients in every category do not tolerate or adhere to CPAP treatment.

Cpap is a very effective treatment but it is not the best sleep apnea treatment for those patients who do not use it. A recent study showed 60% of patients abandon CPAP. In other words when compliance is factored in the majority of patients are not helped by CPAP'

Dental Sleep Medicine and Oral Appliances may be the best sleep apnea treatment for the majority of patients. Even though they may not be as effective as CPAP they are far more effective than no treatment.

Cardiologists recognize that "the undertreated OSA patient at risk of development or worsening of comorbid medical conditions, including hypertension and cardiovascular disease.". They are also aware of the poor compliance that plagues CPAP.

The concerned and informed cardiologists are now recognizing that CPAP is a dismal failure for the majority of sleep apnea patients and are starting to refer more patients for oral appliance therapy. When patients lives are at stake there must be alternatives to CPAP offered to the patients who do not tolerate CPAP. Regardless of the effectiveness of CPAP it is a worthless treatment if it is not used.

Dental Sleep Medicine offers life-changing alternatives to CPAP to cardiac patients who do not tolerate CPAP.

Respir Care. 2010 Sep;55(9):1230-9.
Encouraging CPAP Adherence: It Is Everyone's Job.
Bollig SM.

Hays Medical Center-Sleep and Neurodiagnostic Institute, 2500 Canterbury Drive, Suite 108, Hays KS 67601. suzanne.bollig@haysmed.com.
Abstract
Obstructive sleep apnea (OSA) is a chronic disease treated effectively with the use of continuous positive airway pressure (CPAP) therapy. Patient adherence to prescribed CPAP is variable, however, leaving . The severity of disease and the presence of daytime sleepiness appear to have some predictive quality for subsequent adherence, though a search for consistent predictive factors related to CPAP adherence has proven elusive. Other influences, such as sex, age, socioeconomic status, and personality traits are less robust predictors. The use of sophisticated therapy modalities such as auto-titration or bi-level PAP units has been shown to improve adherence in certain subsets of OSA patients. Adverse effects such as nasal congestion, dry mouth, or skin irritation occur in approximately 50% of CPAP users, and addressing these adverse effects may improve adherence in some patients. More encouraging, studies on the use of intensive patient education and behavioral interventions have shown more positive effects on adherence, leading to the conclusion that improvement in patient adherence to CPAP therapy requires a multi-layered approach, using combined technological, behavioral, and adverse-effect interventions.

PMID: 20800003 [PubMed - in process]

Tuesday, August 31, 2010

Dangers of Sleep Apnea

Sleep apnea is the cessation of breathing for more than 10 seconds while you are asleep. Most people who suffer from sleep apnea experience several episodes per night. Beyond just the regular tiredness and snoring associated with sleep apnea, sleep apnea can have serious side effects.

Due to the lack of sleep, since sleep apnea sufferers generally wake a few times per hour without knowing, patients may experience depression, irritability, and anxiety. They often combat these symptoms with pharmaceutical drugs, but it does not treat the root of the problem: sleep apnea. Addressing your sleep apnea can improve your mood and undo the negative effects lack of sleep was having on your personality.

A lack of sleep can also cause patients to lose concentration and gain weight. Your performance at work or at home can be negatively affected by your body's inability to sleep through the night. Weight gain is also commonly associated with inadequate sleep due to an increased appetite.

Sleep apnea has been linked with more serious side effects such as heart complications. The lack of oxygen to the brain is dangerous and can cause the body to function improperly.

Sleep apnea is dangerous, but you do not have to suffer with CPAP to help you sleep through the night. Let one of our dentists at I Hate CPAP! help you sleep soundly tonight by contacting them today. We serve patients all over the U.S.

Sunday, August 29, 2010

ORAL APPLIANCES TREATING SLEEP APNEA REDUCE BLOOD PRESSURE SIMILAR TO CPAP.

WELL IT IS WELL ESTABLISHED THAT ORAL APPLIANCES ARE EFFECTIVE IN TREATING SLEEP APNEA AND SNORING THIS ARTICLE SHOWS IT ALSO REDUCES BLOOD PRESSURE SIMILAR TO CPAP TREATMENT.

HEAVY SNORING HAS BEEN SHOWN TO INCREASE CAROTID ATHEROSCLEROSIS DUE TO VIBRATIONS. THIS IS ALSO WELL TREATED BY ORAL APPLIANCE THERAPY.

IF SLEEP APNEA IS ELIMINATED THAN THE DISORDERS RELATED TO THE DISORDER WILL ALSO BE ELIMINATED. I EXPECT THAT RESEARCH WILL CONTINUE TO SHOW THAT ORAL APPLIANCES ARE EQUAL TO CPAP WHEN SLEEP APNEA IS SUCCESSFULLY TREATED.

BECAUSE 60% OF PATIENTS ABANDON CPAP IT IS INEFFECTIVE FOR THOSE PATIENTS. SIMPLY STATED CPAP DOES NOT SUCCESSFULLY TREAT ANY DISORDERS IN THE 60% OF PATIENT WHO DO NOT USE IT.

WHAT IS THE BEST SLEEP APNEA TREATMENT? THE BEST SLEEP APNEA TREATMENT IS BOTH EFFECTIVE AND IS USED BY PATIENTS.

THE BEST TREATMENT WILL ALWAYS BE A TREATMENT THAT IS USED BY THE PATIENT. COMFORTABLE ORAL APPLIANCES ARE PREFERRED OVER CPAP BY MOST PATIENTS OFFERED A CHOICE.

Sleep. 2004 Aug 1;27(5):934-41.
Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial.

Gotsopoulos H, Kelly JJ, Cistulli PA.
Department of Respiratory & Sleep Medicine, St George Hospital, The University of New South Wales, Sydney Australia.
Comment in:
Sleep. 2004 Aug 1;27(5):842-3.

Abstract

STUDY OBJECTIVE: To investigate the short-term effect (4 weeks) of oral appliance therapy for obstructive sleep apnea on blood pressure.
DESIGN: Randomized, controlled, crossover trial.
SETTING: Multidisciplinary sleep disorders clinic in a university teaching hospital.
PATIENTS: Sixty-one patients diagnosed with obstructive sleep apnea on polysomnography (apnea hypopnea index > or = 10 per hour and at least 2 of the following symptoms--daytime sleepiness, snoring, witnessed apneas, fragmented sleep; age > 20 years; and minimum mandibular protrusion of 3 mm).
INTERVENTION: A mandibular advancement splint (MAS) and control oral appliance for 4 weeks each.
MEASUREMENTS AND RESULTS: Polysomnography and 24-hour ambulatory blood pressure monitoring were carried out at baseline and following each 4-week intervention period. Patients showed a 50% reduction in mean apnea hypopnea index with MAS compared with the control and a significant improvement in both minimum oxygen saturation and arousal index. There was a significant reduction with the MAS in mean (+/- SEM) 24-hour diastolic blood pressure (1.8 +/- 0.5 mmHg) compared with the control (P = .001) but not in 24-hour systolic blood pressure. Awake blood-pressure variables were reduced with the MAS by an estimated mean (+/- SEM) of 3.3 +/- 1.1 mmHg for systolic blood pressure (P = .003) and 3.4 +/- 0.9 mmHg for diastolic blood pressure (P < .0001). There was no significant difference in blood pressure measured asleep.
CONCLUSION: Oral appliance therapy for obstructive sleep apnea over 4 weeks results in a reduction in blood pressure, similar to that reported with continuous positive airway pressure therapy.

Tuesday, August 24, 2010

The Best Snoring Treatment Is an Oral Appliance

Snoring is a warning sign of sleep apnea. Even snoring without sleep apnea is dangerous. A recent stuy showed snorers had an increased risk of carotid atherosclerosis and/or stroke. Patients with snoring have up to 300% increase in motor vehicle accidents. An Oral Appliance used for sleep apnea will also eliminate snoring. There are many appliances to control snoring and apnea. The TAP appliance has a volume control for the bed partner of the snorer.

ORAL APPLIANCES TREATING SLEEP APNEA REDUCE BLOOD PRESSURE SIMILAR TO CPAP.

A FREQUENT QUESTION IS WHETHER SLEEP APNEA IS BEST TREATED WITH CPAP OR ORAL APPLIANCES. ARE THE MEDICAL RESULTS AS EFFECTIVE WITH ORAL APPLIANCES? THE RESEARCH SAYS ORAL APPLIANCES ARE AS EFFECTIVE AS CPAP IN REDUCING SYMPTOMS WHEN IT IS USED EFFECTIVELY.

THE BEST SLEEP APNEA TREATMENT IS ONE THAT IS USED ON A REGULAR BASIS. IT IS WELL ESTABLISHED THAT CPAP FAILS THE MAJORITY OF PATIENTS DUE TO COMPLIANCE ISSUES. WHEN COMPLIACE IS FACTORED INTO TREATMENT EFFECTIVENESS ORAL APPLIANCES ARE THE MOST EFFECTIVE AND BEST TREATMENT OF MILD TO MODERATE SLEEP APNEA. ORAL APPLIANCE EFFICACY MUST BE CONFIRMED BY OVERNIGHT POLYSOMNOGRAPHY.

CARDIOLOGISTS ARE RECOGNIZING THAT CPAP TYHERAPY IS INEFFECTIVE IN MOST PATIENTS DUE TO POOR COMPLIANCE.

Sleep. 2004 Aug 1;27(5):934-41.
Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial.

Gotsopoulos H, Kelly JJ, Cistulli PA.
Department of Respiratory & Sleep Medicine, St George Hospital, The University of New South Wales, Sydney Australia.
Comment in:
Sleep. 2004 Aug 1;27(5):842-3.

Abstract

STUDY OBJECTIVE: To investigate the short-term effect (4 weeks) of oral appliance therapy for obstructive sleep apnea on blood pressure.
DESIGN: Randomized, controlled, crossover trial.
SETTING: Multidisciplinary sleep disorders clinic in a university teaching hospital.
PATIENTS: Sixty-one patients diagnosed with obstructive sleep apnea on polysomnography (apnea hypopnea index > or = 10 per hour and at least 2 of the following symptoms--daytime sleepiness, snoring, witnessed apneas, fragmented sleep; age > 20 years; and minimum mandibular protrusion of 3 mm).
INTERVENTION: A mandibular advancement splint (MAS) and control oral appliance for 4 weeks each.
MEASUREMENTS AND RESULTS: Polysomnography and 24-hour ambulatory blood pressure monitoring were carried out at baseline and following each 4-week intervention period. Patients showed a 50% reduction in mean apnea hypopnea index with MAS compared with the control and a significant improvement in both minimum oxygen saturation and arousal index. There was a significant reduction with the MAS in mean (+/- SEM) 24-hour diastolic blood pressure (1.8 +/- 0.5 mmHg) compared with the control (P = .001) but not in 24-hour systolic blood pressure. Awake blood-pressure variables were reduced with the MAS by an estimated mean (+/- SEM) of 3.3 +/- 1.1 mmHg for systolic blood pressure (P = .003) and 3.4 +/- 0.9 mmHg for diastolic blood pressure (P < .0001). There was no significant difference in blood pressure measured asleep.
CONCLUSION: Oral appliance therapy for obstructive sleep apnea over 4 weeks results in a reduction in blood pressure, similar to that reported with continuous positive airway pressure therapy

WHAT IS THE BEST ORAL APPLIANCE:MAD VS TRD

I AM FREQUENTLY ASKED WHAT IS THE BEST ORAL APPLIANCE. THIS IS A RECENT ARTICLE PUBLISHED IN THE JOURNAL SLEEP.

IT COMPARES TONGUE STABILIZATION WITH MANDIBULAR ADVANCEMENT APPLIANCES.

MANDIBULAR ADVANCEMENT APPPLIANCES HAVE BETTER COMPLIANCE, IE PATIENTS USED THEM MORE. I THINK THAT PATIENTS NEED TO SEE SLEEP APNEA DENTISTS WITH EXPERIENCE WITH MANY TYPES OF APPLIANCE AND WHO UNDERSTAND TMJ DISORDERS AND NEUROMUSCULAR DENTISTRY.

THERE IS NO BEST ORAL APPLIANCE BUT THERE MAY BE A BEST APPLIANCE FOR A SPECIFIC PATIENT AND SPECIFIC SYMPTOMS AN ANATOMY.

Sleep. 2009 May 1;32(5):648-53.
Comparison of mandibular advancement splint and tongue stabilizing device in obstructive sleep apnea: a randomized controlled trial.

Deane SA, Cistulli PA, Ng AT, Zeng B, Petocz P, Darendeliler MA.
Department of Orthodontics, Faculty of Dentistry, University of Sydney, Sydney Dental Hospital, Sydney, Australia.
Erratum in:
Sleep. 2009 Aug 1;32(8):table of contents.

Abstract

STUDY OBJECTIVES: To compare the efficacy of a mandibular advancement splint (MAS) and a novel tongue stabilizing device (TSD) in the treatment of obstructive sleep apnea (OSA).
DESIGN: A randomized crossover design was used.
PATIENTS: Twenty-seven patients (20 male, 7 female), recruited from a tertiary hospital sleep clinic.
MEASUREMENTS AND RESULTS: The apnea-hypopnea index (AHI) was reduced with MAS (11.68 +/- 8.94, P = 0.000) and TSD (13.15 +/- 10.77, P = 0.002) compared with baseline (26.96 +/- 17.17). The arousal index decreased for MAS (21.09 +/- 9.27, P = 0.004) and TSD (21.9 +/- 10.56, P = 0.001) compared with baseline (33.23 +/- 16.41). Sixty-eight percent of patients achieved a complete or partial response with MAS, compared with 45% with TSD. The Epworth Sleepiness Scale (ESS) score was decreased with MAS (P = < 0.001) and TSD (P = 0.002). Subjective improvements in snoring and quality of sleep were reported, with a better response for MAS than TSD. Compliance was poorer for TSD, and the side effect profiles of the 2 modalities were different. All patients were satisfied with MAS compared to TSD, and 91% of patients preferred the MAS.
CONCLUSION: Objective testing showed the MAS and TSD had similar efficacy in terms of AHI reduction. Patients reported improvements with both devices; however, better compliance and a clear preference for MAS was apparent when both devices were offered. Longer term studies are needed to clarify the role of TSD

Dangerous Consequences of Pediatric Sleep Apnea: Diagnosing and treating sleep apnea is vital to lifetime quality of life.

Question from Sylvia: What are the most common symptoms in children with sleep apnea? Does it affect their brain if left untreated

Dr Shapira Response: Dear Sylvia,
Great Question! There are many short term and long term problems related to sleep apnea. 80% of all ADD and ADHD are related to apnea. There are studies that show both delayed development and permanent changes in brain devlopment.

There are also hormonal (endocrine) changes that affect growth and development.

It is vitally important to children of all ages to iagnose and treat sleep apnea ASAP. Children may never recover from damages that occur in their first few years of life. I have publishe just a few studies below. Recent studies have shown tonsilectomy and adenoid removal may be insufficient treatment and that palatal widening is usually indicated in these patients. Pediatric may be better treated by doing rapid maxillary expansion prior to T&A surgery to create a better post-op healing situation.

It is never to soon to treat sleep apnea. snoring and even minimal apnea AHI of 1 or more should never be ignored but rather taken as an ominus sign of future developmental problems that can be prevented.

I would like to offer my highest recommendation to Dr Alexander Golbin at Sleep and Behavioral Medicine for Chicago area patients. Dr Ira L Shapira

See Pub Med abstracts below:

Pediatr Pulmonol. 2009 May;44(5):417-22.
Neurocognitive and behavioral impact of sleep disordered breathing in children.
Owens JA.

Department of Ambulatory Pediatrics, Rhode Island Hospital, Providence, Rhode Island 02903, USA. owensleep@gmail.com
Abstract
The consequences of poor quality and/or inadequate sleep in children and adolescents have become a major public health concern, and one in which pediatric health care professionals have become increasingly involved. In particular, insufficient and/or fragmented sleep resulting from primary sleep disorders such as obstructive sleep apnea (OSA), often compounded by the presence of comorbid sleep disorders as well as by voluntary sleep curtailment related to lifestyle and environmental factors, has been implicated in a host of negative consequences. These range from metabolic dysfunction and increased cardiovascular morbidity to impairments in mood and academic performance. The following review will focus on what is currently known about the effects of sleep disordered breathing (SDB) specifically on neurobehavioral and neurocognitive function in children. Because of the scarcity of literature on the cognitive and behavioral impact of sleep disorders in infants and very young children, this review will target largely the preschool/school-aged child and adolescent populations. In addition, the focus will be on a review of the most recent literature, as a supplement to several excellent previous reviews on the topic.

Sleep Med. 2010 Aug;11(7):714-20.
Autonomic alterations and endothelial dysfunction in pediatric obstructive sleep apnea.
Kheirandish-Gozal L, Bhattacharjee R, Gozal D.

Department of Pediatrics and Comer Children's Hospital, Pritzker School of Medicine, The University of Chicago, IL 60637, USA. lgozal@peds.bsd.uchicago.edu
Abstract
The cardiovascular consequences of obstructive sleep apnea syndrome (OSAS) in children have started to emerge over the last decade. It is clear that the respiratory and sleep alterations that characterize this relatively prevalent condition induce substantial alterations in autonomic nervous system control, ultimately generating high sympathetic outflow and reactivity that reflect an imbalance between sympatho-excitatory and vagal inhibitory inputs. In addition to these important consequences, the constitutive elements of OSAS also elicit a rather extensive activation of systemic inflammatory pathways that in turn pose substantial risk to the integrity and functional homeostasis of the endothelial network. The complex interactions between the multiple injury-associated pathways recruited by OSAS are further compounded by the potential release of angiogenic factors and by the mobilization and homing of progenitor cells that have the potential to repair and restore the OSAS-disrupted vascular function. Improved characterization of the mechanisms involved in every one of these processes and identification of the determinants of susceptibility in pediatric populations along with the interactions with obesity will clearly modify our approaches to OSAS in the future.

PMID: 20620107 [PubMed - in process]

Clin Chest Med. 2010 Jun;31(2):221-34.
Pediatric obstructive sleep apnea syndrome.
Katz ES, D'Ambrosio CM.

Division of Respiratory Diseases, Department of Medicine, Children's Hospital, Mailstop 208, 300 Longwood Avenue, Boston, MA 02115, USA. eliot.katz@childrens.harvard.edu
Abstract
Obstructive sleep apnea syndrome (OSAS) is a common and serious cause of metabolic, cardiovascular, and neurocognitive morbidity in children. Children with OSAS have increased upper airway resistance during sleep due to a combination of soft tissue hypertrophy, craniofacial dysmorphology, neuromuscular weakness, or obesity. Consequently, children with OSAS encounter a combination of oxidative stress, inflammation, autonomic activation, and disruption of sleep homeostasis. The threshold amount of OSAS associated with adverse consequences varies widely among children, depending on genetic and environmental factors. The choice of therapy is predicated on the etiology, severity, and natural history of the increased upper airway resistance.

PMID: 20488283 [PubMed - in process]

Pediatr Ann. 2008 Jul;37(7):465-70.
The snoring child.
Perez IA, Ward SL.

Keck School of Medicine, University of Southern California, Division of Pediatric Pulmonology, Childrens Hospital Los Angeles, 90027-6062, USA.
Abstract
Snoring is a common manifestation of obstructive sleep apnea and represents one end of the spectrum of sleep-related breathing disorders. Children with primary snoring initially may develop OSAS later, so inquiring about symptoms of OSAS should be part of each visit. Obstructive sleep apnea can result in serious cardiovascular and metabolic consequences and neurocognitive deficits. Adenotonsillar hypertrophy remains the most common cause of OSA although the rising prevalence of obesity is of increasing importance. Polysomnography remains the gold standard in the diagnoses of OSAS and in assessing the risks associated with surgery. Most children with OSAS can be treated with adenotonsillectomy in the ambulatory surgery center. However, there are children at risk for severe OSAS and for postoperative complications, who will need PICU care. In addition to adenotonsillectomy, OSAS can be treated successfully in referral centers with other surgical approaches and by the use of positive airway pressure. Children with obesity-related OSAS often require CPAP or BPAP for control of OSAS.

PMID: 18710136 [PubMed - indexed for MEDLINE]

http://www.ihateheadaches.org/